Gastroenterology General Needs Assessment

Question Title

* 1. In which province or territory do you practice?

Alberta

British Columbia

Manitoba

New Brunswick

Newfoundland and Labrador

Northwest Territories

Nova Scotia

Nunavut

Ontario

Prince Edward Island

Quebec

Saskatchewan

Yukon

Question Title

* 2. What is your area of practice?

Family Medicine

Nursing / Nurse Practitioner

Licensed Practical Nurse (Registered Practical Nurse in Ontario)

Registered Psychiatric Nurse

Pharmacist (includes Community and Hospital Pharmacists)

Student/Intern/Resident

Specialty (please specify):

Question Title

* 3. Other (e.g. Nutritionist / Dietician): please specify

Question Title

* 4. How many years have you been in practice?

0-5

6-10

11-15

16-25

≥ 26

Question Title

* 5. Please specify your type of practice.

Solo

Small group (1-4)

Large group (> 4)

Research

Policy

Administration

Other (please specify)

Question Title

* 6. How would you describe the area in which you practice?

Rural (population < 50,000)

Urban (population ≥ 50,000)

Question Title

* 7. Please specify your main affiliation

Academic (university/ teaching hospital)

Community-based hospital

Clinic

Private practice

Other (please specify)

Question Title

* 8. In an average week, approximately how many patients with gastrointestinal symptoms do you treat in your practice?

On a daily basis

More than once per week but less than daily

1 to 4 times per month

Less than once per month

Question Title

* 9. Based on the following topics, please rate your current level of knowledge or awareness of the following gastrointestinal (GI) conditions, where: 1 = low and 5 = high.

	1 = Low	2	3	4	5 = High
Etiology of common GI conditions	Etiology of common GI conditions 1 = Low	Etiology of common GI conditions 2	Etiology of common GI conditions 3	Etiology of common GI conditions 4	Etiology of common GI conditions 5 = High
Updated guidelines for treatment of C. difficile infection	Updated guidelines for treatment of C. difficile infection 1 = Low	Updated guidelines for treatment of C. difficile infection 2	Updated guidelines for treatment of C. difficile infection 3	Updated guidelines for treatment of C. difficile infection 4	Updated guidelines for treatment of C. difficile infection 5 = High
The most common signs and symptoms of Gastrointestinal disorders	The most common signs and symptoms of Gastrointestinal disorders 1 = Low	The most common signs and symptoms of Gastrointestinal disorders 2	The most common signs and symptoms of Gastrointestinal disorders 3	The most common signs and symptoms of Gastrointestinal disorders 4	The most common signs and symptoms of Gastrointestinal disorders 5 = High
New strategies and treatments for common GI disorders	New strategies and treatments for common GI disorders 1 = Low	New strategies and treatments for common GI disorders 2	New strategies and treatments for common GI disorders 3	New strategies and treatments for common GI disorders 4	New strategies and treatments for common GI disorders 5 = High
Updated guidelines for the use of biologics in inflammatory bowel disease (IBD)	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 1 = Low	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 2	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 3	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 4	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 5 = High
Therapeutic drug monitoring in IBD treatment	Therapeutic drug monitoring in IBD treatment 1 = Low	Therapeutic drug monitoring in IBD treatment 2	Therapeutic drug monitoring in IBD treatment 3	Therapeutic drug monitoring in IBD treatment 4	Therapeutic drug monitoring in IBD treatment 5 = High
Managing GI complications of immunotherapy	Managing GI complications of immunotherapy 1 = Low	Managing GI complications of immunotherapy 2	Managing GI complications of immunotherapy 3	Managing GI complications of immunotherapy 4	Managing GI complications of immunotherapy 5 = High
Management of refractory Gastroesophageal reflux disease (GERD)	Management of refractory Gastroesophageal reflux disease (GERD) 1 = Low	Management of refractory Gastroesophageal reflux disease (GERD) 2	Management of refractory Gastroesophageal reflux disease (GERD) 3	Management of refractory Gastroesophageal reflux disease (GERD) 4	Management of refractory Gastroesophageal reflux disease (GERD) 5 = High
Improved management of (irritable bowel syndrome IBS)	Improved management of (irritable bowel syndrome IBS) 1 = Low	Improved management of (irritable bowel syndrome IBS) 2	Improved management of (irritable bowel syndrome IBS) 3	Improved management of (irritable bowel syndrome IBS) 4	Improved management of (irritable bowel syndrome IBS) 5 = High
Techniques to effectively control acute GI bleeding	Techniques to effectively control acute GI bleeding 1 = Low	Techniques to effectively control acute GI bleeding 2	Techniques to effectively control acute GI bleeding 3	Techniques to effectively control acute GI bleeding 4	Techniques to effectively control acute GI bleeding 5 = High
Steps to ensure delivery of high-quality colonoscopic care	Steps to ensure delivery of high-quality colonoscopic care 1 = Low	Steps to ensure delivery of high-quality colonoscopic care 2	Steps to ensure delivery of high-quality colonoscopic care 3	Steps to ensure delivery of high-quality colonoscopic care 4	Steps to ensure delivery of high-quality colonoscopic care 5 = High
Hereditary GI Cancer Syndromes and Genetic Testing	Hereditary GI Cancer Syndromes and Genetic Testing 1 = Low	Hereditary GI Cancer Syndromes and Genetic Testing 2	Hereditary GI Cancer Syndromes and Genetic Testing 3	Hereditary GI Cancer Syndromes and Genetic Testing 4	Hereditary GI Cancer Syndromes and Genetic Testing 5 = High
Management of fatty liver disease	Management of fatty liver disease 1 = Low	Management of fatty liver disease 2	Management of fatty liver disease 3	Management of fatty liver disease 4	Management of fatty liver disease 5 = High
Best practices for treatment of hepatitis C	Best practices for treatment of hepatitis C 1 = Low	Best practices for treatment of hepatitis C 2	Best practices for treatment of hepatitis C 3	Best practices for treatment of hepatitis C 4	Best practices for treatment of hepatitis C 5 = High
Immunotherapy strategies in various GI malignancies	Immunotherapy strategies in various GI malignancies 1 = Low	Immunotherapy strategies in various GI malignancies 2	Immunotherapy strategies in various GI malignancies 3	Immunotherapy strategies in various GI malignancies 4	Immunotherapy strategies in various GI malignancies 5 = High
Drug therapy versus dietary therapy in GI treatment	Drug therapy versus dietary therapy in GI treatment 1 = Low	Drug therapy versus dietary therapy in GI treatment 2	Drug therapy versus dietary therapy in GI treatment 3	Drug therapy versus dietary therapy in GI treatment 4	Drug therapy versus dietary therapy in GI treatment 5 = High
The stool microbiome (the science behind clinical applications)	The stool microbiome (the science behind clinical applications) 1 = Low	The stool microbiome (the science behind clinical applications) 2	The stool microbiome (the science behind clinical applications) 3	The stool microbiome (the science behind clinical applications) 4	The stool microbiome (the science behind clinical applications) 5 = High
Managing refractory pouchitis	Managing refractory pouchitis 1 = Low	Managing refractory pouchitis 2	Managing refractory pouchitis 3	Managing refractory pouchitis 4	Managing refractory pouchitis 5 = High
Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 1 = Low	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 2	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 3	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 4	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 5 = High
Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 1 = Low	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 2	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 3	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 4	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 5 = High
Recommendations/guidelines for the management of celiac disease	Recommendations/guidelines for the management of celiac disease 1 = Low	Recommendations/guidelines for the management of celiac disease 2	Recommendations/guidelines for the management of celiac disease 3	Recommendations/guidelines for the management of celiac disease 4	Recommendations/guidelines for the management of celiac disease 5 = High
Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease)	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 1 = Low	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 2	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 3	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 4	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 5 = High
Pharmacotherapy for gastrointestinal disorders	Pharmacotherapy for gastrointestinal disorders 1 = Low	Pharmacotherapy for gastrointestinal disorders 2	Pharmacotherapy for gastrointestinal disorders 3	Pharmacotherapy for gastrointestinal disorders 4	Pharmacotherapy for gastrointestinal disorders 5 = High
Common Gastrointestinal Conditions in pregnancy	Common Gastrointestinal Conditions in pregnancy 1 = Low	Common Gastrointestinal Conditions in pregnancy 2	Common Gastrointestinal Conditions in pregnancy 3	Common Gastrointestinal Conditions in pregnancy 4	Common Gastrointestinal Conditions in pregnancy 5 = High
Common GI conditions in Pediatrics	Common GI conditions in Pediatrics 1 = Low	Common GI conditions in Pediatrics 2	Common GI conditions in Pediatrics 3	Common GI conditions in Pediatrics 4	Common GI conditions in Pediatrics 5 = High
Recommendations/guidelines for the management of constipation	Recommendations/guidelines for the management of constipation 1 = Low	Recommendations/guidelines for the management of constipation 2	Recommendations/guidelines for the management of constipation 3	Recommendations/guidelines for the management of constipation 4	Recommendations/guidelines for the management of constipation 5 = High
Smoking and GI disorders	Smoking and GI disorders 1 = Low	Smoking and GI disorders 2	Smoking and GI disorders 3	Smoking and GI disorders 4	Smoking and GI disorders 5 = High
Helicobacter pylori (H. pylori) and GI disorders	Helicobacter pylori (H. pylori) and GI disorders 1 = Low	Helicobacter pylori (H. pylori) and GI disorders 2	Helicobacter pylori (H. pylori) and GI disorders 3	Helicobacter pylori (H. pylori) and GI disorders 4	Helicobacter pylori (H. pylori) and GI disorders 5 = High
Impact of COVID-19 on GI practice	Impact of COVID-19 on GI practice 1 = Low	Impact of COVID-19 on GI practice 2	Impact of COVID-19 on GI practice 3	Impact of COVID-19 on GI practice 4	Impact of COVID-19 on GI practice 5 = High

Question Title

* 10. Based on the following topics, please rate your desired level of knowledge or awareness of the following gastrointestinal (GI) conditions, where: 1 = low and 5 = high.

	1 = Low	2	3	4	5 = High
Etiology of common GI conditions	Etiology of common GI conditions 1 = Low	Etiology of common GI conditions 2	Etiology of common GI conditions 3	Etiology of common GI conditions 4	Etiology of common GI conditions 5 = High
Updated guidelines for treatment of C. difficile infection	Updated guidelines for treatment of C. difficile infection 1 = Low	Updated guidelines for treatment of C. difficile infection 2	Updated guidelines for treatment of C. difficile infection 3	Updated guidelines for treatment of C. difficile infection 4	Updated guidelines for treatment of C. difficile infection 5 = High
The most common signs and symptoms of Gastrointestinal disorders	The most common signs and symptoms of Gastrointestinal disorders 1 = Low	The most common signs and symptoms of Gastrointestinal disorders 2	The most common signs and symptoms of Gastrointestinal disorders 3	The most common signs and symptoms of Gastrointestinal disorders 4	The most common signs and symptoms of Gastrointestinal disorders 5 = High
New strategies and treatments for common GI disorders	New strategies and treatments for common GI disorders 1 = Low	New strategies and treatments for common GI disorders 2	New strategies and treatments for common GI disorders 3	New strategies and treatments for common GI disorders 4	New strategies and treatments for common GI disorders 5 = High
Updated guidelines for the use of biologics in inflammatory bowel disease (IBD)	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 1 = Low	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 2	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 3	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 4	Updated guidelines for the use of biologics in inflammatory bowel disease (IBD) 5 = High
Therapeutic drug monitoring in IBD treatment	Therapeutic drug monitoring in IBD treatment 1 = Low	Therapeutic drug monitoring in IBD treatment 2	Therapeutic drug monitoring in IBD treatment 3	Therapeutic drug monitoring in IBD treatment 4	Therapeutic drug monitoring in IBD treatment 5 = High
Managing GI complications of immunotherapy	Managing GI complications of immunotherapy 1 = Low	Managing GI complications of immunotherapy 2	Managing GI complications of immunotherapy 3	Managing GI complications of immunotherapy 4	Managing GI complications of immunotherapy 5 = High
Management of refractory Gastroesophageal reflux disease (GERD)	Management of refractory Gastroesophageal reflux disease (GERD) 1 = Low	Management of refractory Gastroesophageal reflux disease (GERD) 2	Management of refractory Gastroesophageal reflux disease (GERD) 3	Management of refractory Gastroesophageal reflux disease (GERD) 4	Management of refractory Gastroesophageal reflux disease (GERD) 5 = High
Improved management of (irritable bowel syndrome IBS)	Improved management of (irritable bowel syndrome IBS) 1 = Low	Improved management of (irritable bowel syndrome IBS) 2	Improved management of (irritable bowel syndrome IBS) 3	Improved management of (irritable bowel syndrome IBS) 4	Improved management of (irritable bowel syndrome IBS) 5 = High
Techniques to effectively control acute GI bleeding	Techniques to effectively control acute GI bleeding 1 = Low	Techniques to effectively control acute GI bleeding 2	Techniques to effectively control acute GI bleeding 3	Techniques to effectively control acute GI bleeding 4	Techniques to effectively control acute GI bleeding 5 = High
Steps to ensure delivery of high-quality colonoscopic care	Steps to ensure delivery of high-quality colonoscopic care 1 = Low	Steps to ensure delivery of high-quality colonoscopic care 2	Steps to ensure delivery of high-quality colonoscopic care 3	Steps to ensure delivery of high-quality colonoscopic care 4	Steps to ensure delivery of high-quality colonoscopic care 5 = High
Hereditary GI Cancer Syndromes and Genetic Testing	Hereditary GI Cancer Syndromes and Genetic Testing 1 = Low	Hereditary GI Cancer Syndromes and Genetic Testing 2	Hereditary GI Cancer Syndromes and Genetic Testing 3	Hereditary GI Cancer Syndromes and Genetic Testing 4	Hereditary GI Cancer Syndromes and Genetic Testing 5 = High
Management of fatty liver disease	Management of fatty liver disease 1 = Low	Management of fatty liver disease 2	Management of fatty liver disease 3	Management of fatty liver disease 4	Management of fatty liver disease 5 = High
Best practices for treatment of hepatitis C	Best practices for treatment of hepatitis C 1 = Low	Best practices for treatment of hepatitis C 2	Best practices for treatment of hepatitis C 3	Best practices for treatment of hepatitis C 4	Best practices for treatment of hepatitis C 5 = High
Immunotherapy strategies in various GI malignancies	Immunotherapy strategies in various GI malignancies 1 = Low	Immunotherapy strategies in various GI malignancies 2	Immunotherapy strategies in various GI malignancies 3	Immunotherapy strategies in various GI malignancies 4	Immunotherapy strategies in various GI malignancies 5 = High
Drug therapy versus dietary therapy in GI treatment	Drug therapy versus dietary therapy in GI treatment 1 = Low	Drug therapy versus dietary therapy in GI treatment 2	Drug therapy versus dietary therapy in GI treatment 3	Drug therapy versus dietary therapy in GI treatment 4	Drug therapy versus dietary therapy in GI treatment 5 = High
The stool microbiome (the science behind clinical applications)	The stool microbiome (the science behind clinical applications) 1 = Low	The stool microbiome (the science behind clinical applications) 2	The stool microbiome (the science behind clinical applications) 3	The stool microbiome (the science behind clinical applications) 4	The stool microbiome (the science behind clinical applications) 5 = High
Managing refractory pouchitis	Managing refractory pouchitis 1 = Low	Managing refractory pouchitis 2	Managing refractory pouchitis 3	Managing refractory pouchitis 4	Managing refractory pouchitis 5 = High
Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 1 = Low	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 2	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 3	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 4	Prevention of antibiotic associated diarrhea (AAD) based upon current clinical evidence 5 = High
Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 1 = Low	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 2	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 3	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 4	Prevention of C. difficile associated diarrhea (CDAD) based upon current clinical evidence 5 = High
Recommendations/guidelines for the management of celiac disease	Recommendations/guidelines for the management of celiac disease 1 = Low	Recommendations/guidelines for the management of celiac disease 2	Recommendations/guidelines for the management of celiac disease 3	Recommendations/guidelines for the management of celiac disease 4	Recommendations/guidelines for the management of celiac disease 5 = High
Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease)	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 1 = Low	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 2	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 3	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 4	Recommendations/guidelines for the management of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 5 = High
Pharmacotherapy for gastrointestinal disorders	Pharmacotherapy for gastrointestinal disorders 1 = Low	Pharmacotherapy for gastrointestinal disorders 2	Pharmacotherapy for gastrointestinal disorders 3	Pharmacotherapy for gastrointestinal disorders 4	Pharmacotherapy for gastrointestinal disorders 5 = High
Common Gastrointestinal Conditions in pregnancy	Common Gastrointestinal Conditions in pregnancy 1 = Low	Common Gastrointestinal Conditions in pregnancy 2	Common Gastrointestinal Conditions in pregnancy 3	Common Gastrointestinal Conditions in pregnancy 4	Common Gastrointestinal Conditions in pregnancy 5 = High
Common GI conditions in Pediatrics	Common GI conditions in Pediatrics 1 = Low	Common GI conditions in Pediatrics 2	Common GI conditions in Pediatrics 3	Common GI conditions in Pediatrics 4	Common GI conditions in Pediatrics 5 = High
Recommendations/guidelines for the management of constipation	Recommendations/guidelines for the management of constipation 1 = Low	Recommendations/guidelines for the management of constipation 2	Recommendations/guidelines for the management of constipation 3	Recommendations/guidelines for the management of constipation 4	Recommendations/guidelines for the management of constipation 5 = High
Smoking and GI disorders	Smoking and GI disorders 1 = Low	Smoking and GI disorders 2	Smoking and GI disorders 3	Smoking and GI disorders 4	Smoking and GI disorders 5 = High
Helicobacter pylori (H. pylori) and GI disorders	Helicobacter pylori (H. pylori) and GI disorders 1 = Low	Helicobacter pylori (H. pylori) and GI disorders 2	Helicobacter pylori (H. pylori) and GI disorders 3	Helicobacter pylori (H. pylori) and GI disorders 4	Helicobacter pylori (H. pylori) and GI disorders 5 = High
Impact of COVID-19 on GI practice	Impact of COVID-19 on GI practice 1 = Low	Impact of COVID-19 on GI practice 2	Impact of COVID-19 on GI practice 3	Impact of COVID-19 on GI practice 4	Impact of COVID-19 on GI practice 5 = High

Question Title

* 11. Please rate the frequency with which patients in your practice seek treatment for the following gastrointestinal conditions, where: 1 = low and 5 = high.

	1 = Low	2	3	4	5 = High
Clostridium difficile infection	Clostridium difficile infection 1 = Low	Clostridium difficile infection 2	Clostridium difficile infection 3	Clostridium difficile infection 4	Clostridium difficile infection 5 = High
Antibiotic associated diarrhea	Antibiotic associated diarrhea 1 = Low	Antibiotic associated diarrhea 2	Antibiotic associated diarrhea 3	Antibiotic associated diarrhea 4	Antibiotic associated diarrhea 5 = High
Rectocele and fecal incontinence	Rectocele and fecal incontinence 1 = Low	Rectocele and fecal incontinence 2	Rectocele and fecal incontinence 3	Rectocele and fecal incontinence 4	Rectocele and fecal incontinence 5 = High
Celiac disease	Celiac disease 1 = Low	Celiac disease 2	Celiac disease 3	Celiac disease 4	Celiac disease 5 = High
GERD	GERD 1 = Low	GERD 2	GERD 3	GERD 4	GERD 5 = High
Irritable bowel syndrome (IBS)	Irritable bowel syndrome (IBS) 1 = Low	Irritable bowel syndrome (IBS) 2	Irritable bowel syndrome (IBS) 3	Irritable bowel syndrome (IBS) 4	Irritable bowel syndrome (IBS) 5 = High
Hepatitis C	Hepatitis C 1 = Low	Hepatitis C 2	Hepatitis C 3	Hepatitis C 4	Hepatitis C 5 = High
Constipation	Constipation 1 = Low	Constipation 2	Constipation 3	Constipation 4	Constipation 5 = High
Ulcerative colitis	Ulcerative colitis 1 = Low	Ulcerative colitis 2	Ulcerative colitis 3	Ulcerative colitis 4	Ulcerative colitis 5 = High
Crohn’s disease	Crohn’s disease 1 = Low	Crohn’s disease 2	Crohn’s disease 3	Crohn’s disease 4	Crohn’s disease 5 = High
Liver disease	Liver disease 1 = Low	Liver disease 2	Liver disease 3	Liver disease 4	Liver disease 5 = High
Nutritional disorders related to GI conditions	Nutritional disorders related to GI conditions 1 = Low	Nutritional disorders related to GI conditions 2	Nutritional disorders related to GI conditions 3	Nutritional disorders related to GI conditions 4	Nutritional disorders related to GI conditions 5 = High
Colorectal cancer	Colorectal cancer 1 = Low	Colorectal cancer 2	Colorectal cancer 3	Colorectal cancer 4	Colorectal cancer 5 = High
GI Bleeding	GI Bleeding 1 = Low	GI Bleeding 2	GI Bleeding 3	GI Bleeding 4	GI Bleeding 5 = High
GI Complications of Immunotherapy	GI Complications of Immunotherapy 1 = Low	GI Complications of Immunotherapy 2	GI Complications of Immunotherapy 3	GI Complications of Immunotherapy 4	GI Complications of Immunotherapy 5 = High
Acute and chronic pancreatitis	Acute and chronic pancreatitis 1 = Low	Acute and chronic pancreatitis 2	Acute and chronic pancreatitis 3	Acute and chronic pancreatitis 4	Acute and chronic pancreatitis 5 = High
Lactose intolerance	Lactose intolerance 1 = Low	Lactose intolerance 2	Lactose intolerance 3	Lactose intolerance 4	Lactose intolerance 5 = High
Diverticulitis	Diverticulitis 1 = Low	Diverticulitis 2	Diverticulitis 3	Diverticulitis 4	Diverticulitis 5 = High

Question Title

* 12. Please rate the frequency with which you treat patients experiencing the following gastrointestinal symptoms, where: 1 = low and 5 = high.

	1 = Low	2	3	4	5 = High
Diarrhea	Diarrhea 1 = Low	Diarrhea 2	Diarrhea 3	Diarrhea 4	Diarrhea 5 = High
Constipation	Constipation 1 = Low	Constipation 2	Constipation 3	Constipation 4	Constipation 5 = High
Abdominal discomfort (bloating, pain or cramps)	Abdominal discomfort (bloating, pain or cramps) 1 = Low	Abdominal discomfort (bloating, pain or cramps) 2	Abdominal discomfort (bloating, pain or cramps) 3	Abdominal discomfort (bloating, pain or cramps) 4	Abdominal discomfort (bloating, pain or cramps) 5 = High
Blood in the stool	Blood in the stool 1 = Low	Blood in the stool 2	Blood in the stool 3	Blood in the stool 4	Blood in the stool 5 = High
Flatulence	Flatulence 1 = Low	Flatulence 2	Flatulence 3	Flatulence 4	Flatulence 5 = High
Heartburn	Heartburn 1 = Low	Heartburn 2	Heartburn 3	Heartburn 4	Heartburn 5 = High
Unintentional weight loss	Unintentional weight loss 1 = Low	Unintentional weight loss 2	Unintentional weight loss 3	Unintentional weight loss 4	Unintentional weight loss 5 = High
Acid reflux (heartburn)	Acid reflux (heartburn) 1 = Low	Acid reflux (heartburn) 2	Acid reflux (heartburn) 3	Acid reflux (heartburn) 4	Acid reflux (heartburn) 5 = High
Fecal incontinence	Fecal incontinence 1 = Low	Fecal incontinence 2	Fecal incontinence 3	Fecal incontinence 4	Fecal incontinence 5 = High
Fatigue	Fatigue 1 = Low	Fatigue 2	Fatigue 3	Fatigue 4	Fatigue 5 = High
Loss of appetite	Loss of appetite 1 = Low	Loss of appetite 2	Loss of appetite 3	Loss of appetite 4	Loss of appetite 5 = High
Vomiting and nausea	Vomiting and nausea 1 = Low	Vomiting and nausea 2	Vomiting and nausea 3	Vomiting and nausea 4	Vomiting and nausea 5 = High
Dysphagia	Dysphagia 1 = Low	Dysphagia 2	Dysphagia 3	Dysphagia 4	Dysphagia 5 = High

Question Title

* 13. Is there another topic related to gastrointestinal conditions which you’d like to learn more about?

Yes (please specify)

Question Title

* 14. In order to be eligible to receive one of five gift cards available to be won, please provide your email address. If you are the winner, we will connect with you directly.